Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2022 Results - Earnings Call Transcript
Relmada Therapeutics, Inc. (RLMD) CEO Sergio Traversa on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
0 shares
1 views
You might like
Related news coverage
-
Biora Therapeutics, Inc's (BIOR) CEO Adi Mohanty on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Viridian Therapeutics, Inc. (VRDN) CEO Jonathan Violin on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Alaunos Therapeutics, Inc. (TCRT) CEO Kevin Boyle on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
Advertisement
More coverage
-
Trevi Therapeutics, Inc. (TRVI) CEO Jennifer Good on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Better Therapeutics, Inc. (BTTX) CEO Frank Karbe on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Pear Therapeutics, Inc. (PEAR) CEO Corey McCann on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha
-
Virios Therapeutics, Inc. (VIRI) CEO Greg Duncan on Q2 2022 Results - Earnings Call Transcript
SeekingAlpha